An overview of the role of telomeres and telomerase in pre‑neoplastic lesions (Review).

IF 1.4 Q4 ONCOLOGY Molecular and clinical oncology Pub Date : 2023-08-01 DOI:10.3892/mco.2023.2657
Eleftheria Karaviti, Athanasios Kontogiannis, Aristotelis Anastopoulos, Elias Kotteas, Georgia Gomatou
{"title":"An overview of the role of telomeres and telomerase in pre‑neoplastic lesions (Review).","authors":"Eleftheria Karaviti,&nbsp;Athanasios Kontogiannis,&nbsp;Aristotelis Anastopoulos,&nbsp;Elias Kotteas,&nbsp;Georgia Gomatou","doi":"10.3892/mco.2023.2657","DOIUrl":null,"url":null,"abstract":"<p><p>Telomeres are tandem repeats of DNA sequences protecting the end of linear chromosomes. Replicative senescence due to telomere attrition is considered a tumor-preventing mechanism in differentiated somatic cells. However, telomere shortening is associated with genome instability and several disease entities. During carcinogenesis, the development of a telomere maintenance mechanism, predominately through the activation of the telomerase enzyme, represents a hallmark of cancer, since it enables cancer cells to avert senescence and divide indefinitely. Although research of the involvement of telomeres and telomerase in various malignant neoplasms has gained a large amount of interest, the timing and relevance of their role in pre-neoplastic lesions remain to be determined. The present narrative review aims to summarize the evidence regarding the role of telomeres and telomerase in pre-neoplasia across different types of tissues.</p>","PeriodicalId":18737,"journal":{"name":"Molecular and clinical oncology","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0e/93/mco-19-02-02657.PMC10326563.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular and clinical oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3892/mco.2023.2657","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Telomeres are tandem repeats of DNA sequences protecting the end of linear chromosomes. Replicative senescence due to telomere attrition is considered a tumor-preventing mechanism in differentiated somatic cells. However, telomere shortening is associated with genome instability and several disease entities. During carcinogenesis, the development of a telomere maintenance mechanism, predominately through the activation of the telomerase enzyme, represents a hallmark of cancer, since it enables cancer cells to avert senescence and divide indefinitely. Although research of the involvement of telomeres and telomerase in various malignant neoplasms has gained a large amount of interest, the timing and relevance of their role in pre-neoplastic lesions remain to be determined. The present narrative review aims to summarize the evidence regarding the role of telomeres and telomerase in pre-neoplasia across different types of tissues.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
端粒和端粒酶在肿瘤前病变中的作用综述(综述)。
端粒是DNA序列的串联重复序列,保护线性染色体的末端。端粒损耗引起的复制性衰老被认为是分化体细胞中防止肿瘤发生的一种机制。然而,端粒缩短与基因组不稳定和几种疾病实体有关。在癌变过程中,端粒维持机制的发展,主要是通过端粒酶的激活,代表了癌症的一个标志,因为它使癌细胞避免衰老和无限分裂。尽管端粒和端粒酶参与各种恶性肿瘤的研究已经获得了大量的兴趣,但它们在肿瘤前病变中的作用的时间和相关性仍有待确定。本综述旨在总结关于端粒和端粒酶在不同类型组织的瘤前病变中的作用的证据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.80
自引率
0.00%
发文量
108
期刊最新文献
Breast cancer radiobiology: The renaissance of whole breast radiation fractionation (Review). A computed tomography‑based radio‑clinical model for the prediction of microvascular invasion in gastric cancer. Clinical parameters and postoperative outcomes of pituitary adenomas in children: Analysis according to size of adenomas and adopted surgical procedures. Incidence of myelosuppression in AML is higher compared with that in ALL. Efficacy and safety of second‑generation FLT3 inhibitors in acute myeloid leukemia: A systematic review and meta‑analysis of randomized controlled trials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1